These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10029088)

  • 1. Modulation of the cytotoxicity of 3'-azido-3'-deoxythymidine and methotrexate after transduction of folate receptor cDNA into human cervical carcinoma: identification of a correlation between folate receptor expression and thymidine kinase activity.
    Sun XL; Jayaram HN; Gharehbaghi K; Li QJ; Xiao X; Antony AC
    Cancer Res; 1999 Feb; 59(4):940-6. PubMed ID: 10029088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo.
    Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW
    Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
    Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transduction of folate receptor cDNA into cervical carcinoma cells using recombinant adeno-associated virions delays cell proliferation in vitro and in vivo.
    Sun XL; Murphy BR; Li QJ; Gullapalli S; Mackins J; Jayaram HN; Srivastava A; Antony AC
    J Clin Invest; 1995 Sep; 96(3):1535-47. PubMed ID: 7657824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
    Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
    J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study.
    Fanciullino R; Evrard A; Cuq P; Giacometti S; Peillard L; Mercier C; Aubert C; Milano G; Ciccolini J
    Anticancer Drugs; 2006 Apr; 17(4):463-70. PubMed ID: 16550005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further study of the mechanism underlying the cellular resistance to AZT.
    Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F
    Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of the multitargeted antifolate, MTA (LY231514), in human cell lines with different resistance mechanisms to antifolate drugs.
    Schultz RM; Chen VJ; Bewley JR; Roberts EF; Shih C; Dempsey JA
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):68-73. PubMed ID: 10598558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and biochemical implications of combining AZT and AG-331.
    Pressacco J; Mitrovski B; Erlichman C
    Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
    Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
    Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of leukemia T-cells resistant to methotrexate and 7-hydroxymethotrexate reveals alterations that preserve intracellular levels of folate and nucleotide biosynthesis.
    Fotoohi AK; Assaraf YG; Moshfegh A; Hashemi J; Jansen G; Peters GJ; Larsson C; Albertioni F
    Biochem Pharmacol; 2009 Apr; 77(8):1410-7. PubMed ID: 19426680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier.
    Zhao R; Gao F; Babani S; Goldman ID
    Clin Cancer Res; 2000 Aug; 6(8):3304-11. PubMed ID: 10955817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of reduced folate carrier gene (RFC1) expression after exposure to methotrexate in ZR-75-1 breast cancer cells.
    Ma D; Huang H; Moscow JA
    Biochem Biophys Res Commun; 2000 Dec; 279(3):891-7. PubMed ID: 11162445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3'-Azido-3'-deoxythymidine cytotoxicity and metabolism in the human colon tumor cell line HCT-8.
    Darnowski JW; Goulette FA
    Biochem Pharmacol; 1994 Nov; 48(9):1797-805. PubMed ID: 7980649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse model.
    Emura T; Nakagawa F; Fujioka A; Ohshimo H; Kitazato K
    Oncol Rep; 2004 Feb; 11(2):381-7. PubMed ID: 14719072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of 3'-azido-2',3'-dideoxythymidine resistance to human lymphoid cells.
    Hoever G; Groeschel B; Chandra P; Doerr HW; Cinatl J
    Int J Mol Med; 2003 Jun; 11(6):743-7. PubMed ID: 12736716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen.
    Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ
    Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.